(Q53991675)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593385%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathway (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593385%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

0 references

0 references

cervix uterine cancer

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593385%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Min-Liang Kuo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593385%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Wen-Fang Cheng

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593385%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

Wei LH

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593385%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Chou CH

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593385%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Chang MC

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593385%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Su JL

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593385%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Hsieh CY

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593385%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

English

0 references

publication date

1 September 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593385%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593385%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593385%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

5799-5809

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593385%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593385%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1204733

12 November 2019

exact match

0 references

cites work

The Bcl-2 protein family: arbiters of cell survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204733

Interleukin 1alpha and interleukin 6 promote the in vitro growth of both normal and neoplastic human cervical epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204733

Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204733

Expression of Bcl-2 by human bone marrow mast cells and its overexpression in mast cell leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204733

BCL-2 family: regulators of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204733

mcl-1 is an immediate-early gene activated by the granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling pathway and is one component of the GM-CSF viability response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204733

Prognostic significance of the bcl-2 apoptotic family of proteins in primary and recurrent cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204733

Interleukin-6 (IL-6) functions as an autocrine growth factor in cervical carcinomas in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204733

Overexpression of interleukin-6 in human basal cell carcinoma cell lines increases anti-apoptotic activity and tumorigenic potency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204733

Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204733

MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204733

PIK3CA as an oncogene in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204733

Strategies for global control of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204733

Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204733

Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3'-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204733

Apoptosis in the pathogenesis and treatment of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204733

Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204733

The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204733

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204733

Interleukin-6 inhibits transforming growth factor-beta-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204733

7 January 2021

Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204733

7 January 2021

A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204733

7 January 2021

Oncogene expression in cervical intraepithelial neoplasia and invasive cancer of cervix

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204733

7 January 2021

The association of interleukin 6 with clinical and laboratory parameters of acute pelvic inflammatory disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204733

7 January 2021

Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204733

7 January 2021

A molecular blueprint for targeting cancer?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204733

7 January 2021

Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-α

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204733

7 January 2021